Rockwell Medical (RMTI) Change in Accured Expenses (2016 - 2025)
Rockwell Medical's Change in Accured Expenses history spans 16 years, with the latest figure at $625000.0 for Q4 2025.
- For Q4 2025, Change in Accured Expenses rose 320.85% year-over-year to $625000.0; the TTM value through Dec 2025 reached -$1.7 million, down 62.38%, while the annual FY2025 figure was -$1.7 million, 62.38% down from the prior year.
- Change in Accured Expenses reached $625000.0 in Q4 2025 per RMTI's latest filing, up from -$139000.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $2.9 million in Q3 2023 to a low of -$3.3 million in Q1 2023.
- Average Change in Accured Expenses over 5 years is -$30150.0, with a median of $58000.0 recorded in 2022.
- Peak YoY movement for Change in Accured Expenses: soared 600.0% in 2021, then plummeted 414.84% in 2023.
- A 5-year view of Change in Accured Expenses shows it stood at $777000.0 in 2021, then surged by 128.83% to $1.8 million in 2022, then crashed by 63.05% to $657000.0 in 2023, then tumbled by 143.07% to -$283000.0 in 2024, then surged by 320.85% to $625000.0 in 2025.
- Per Business Quant, the three most recent readings for RMTI's Change in Accured Expenses are $625000.0 (Q4 2025), -$139000.0 (Q3 2025), and -$503000.0 (Q2 2025).